drugset / Trial / NCT01704521
Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Phase 1
Completed
5 enrolled
Kenneth Sherman
Genentech, Inc. · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabVertex Pharmaceuticals Incorporated · collab
RandomizedParallel-groupOpen-label
Summary
This study will examine viral dynamic responses in subjects with chronic hepatitis C and hemophilia when treated with pegylated interferon + ribavirin and telaprevir.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Peginterferon | Protein / enzyme biologic | — | — |
| Comparator | Ribavirin | Small molecule | — | — |
| Comparator | Telaprevir | Small molecule | — | — |